Guangdong Biolight Meditech Co Ltd300246
▼ NegativeCapitalrelevance
Net loss of 34.49 million yuan, swinging from profit to loss, with declining revenue and margins.

Biolight released its 2026 interim report, with net profit attributable to the parent company at negative 34.49 million yuan, swinging from profit to loss. The company's total operating revenue was 518 million yuan, down 1.09% year-on-year. Net cash inflow from operating activities was 67.12 million yuan, the asset-liability ratio rose to 52.11%, gross margin fell to 22.86%, and ROE was negative 3.13%.
Guangdong Biolight Meditech Co LtdNet loss of 34.49 million yuan, swinging from profit to loss, with declining revenue and margins.